Biopharmaceuticals
AI:n luoma kuva
Amazonian scorpion venom peptide shows paclitaxel-like action against breast cancer cells in lab tests
Raportoinut AI AI:n luoma kuva Faktatarkistettu
Researchers in Brazil have identified a molecule in the venom of the Amazonian scorpion Brotheas amazonicus that kills breast cancer cells in vitro with effects similar to the chemotherapy drug paclitaxel, according to FAPESP. Early tests indicate the peptide chiefly induces necrosis, underscoring venoms’ promise as a source of biopharmaceuticals.